Lawsuits Involving Actos-Related Bladder Cancer
Actos was marketed as an effective diabetes medication when it was first introduced in the early 2000s. Offering a way to control blood glucose levels without the risk of side effects, Actos was welcomed by the medical community as well as patients looking for a medication to ease the symptoms of what is a difficult condition.
Far from being totally safe however, Actos has actually been found to cause another serious condition: bladder cancer. If you–like thousands of other diabetes patients who took Actos–have developed bladder cancer, you may be able to file a lawsuit for damages resulting from the use of the drug.
Actos increases risk of bladder cancer
In studies conducted by the U.S. Food and Drug administration, it was found that patients who took Actos for one year or longer in order to control their blood sugar levels had an increased risk of developing bladder cancer compared to diabetes patients that opted for other medications.
Even before the results of the studies were released, two countries in Europe have already banned Actos, although the European Medicines Agency has yet to announce a definitive set of guidelines with regard to the use of the drug.
Higher risk for patients who take Actos longer
Many of the patients that have filed lawsuits against Takeda Pharmaceutical Co.–the company that manufactures Actos–are those that have taken the drug for a year or more. Analysis of a five years’ worth of clinical data reveals that the patients at greater risk of incurring bladder cancer are those that have been exposed to the drug for longer and more
With the filing of hundreds of lawsuits against the manufacturers of Actos, it has become the second thiazolidinedione medication to have been linked with dangerous side effects, with the other being Avandia. Linked to an increased incidence of heart attack in patients who took it, Avandia was itself the subject of numerous lawsuits.
Takeda Pharmaceutical Co. denial of health risks
Officials of Takeda Pharmaceutical Co. have consistently denied that there is a link between the use of Actos and the development of bladder cancer. However, there are reports that company officials were actually aware of the risks of taking the drug, but have routinely sought to cover these up from federal regulatory bodies.
One such report stated that officials of Takeda Pharmaceutical Co. were aware of the dangers of the drug since 2004, but only revealed these findings to U.S. regulatory bodies in 2011. While the company’s sales of Actos reached its high point in 2011, the revelation of its health risks with regard to bladder cancer have caused sales of the drug to fall. In the wake of impending investigations into the risk of Actos, Takeda Pharmaceutical Co. has since been granted approval for an alternative diabetes medication called Nesina.
If you are a diabetic who has taken Actos in the past, and have been diagnosed with bladder cancer, you may be eligible to file a lawsuit against Takeda Pharmaceutical Co. and possibly even the doctor and treatment facility that prescribed the use of the drug. Bladder cancer is a potentially deadly condition, and there is a high incidence of recurrence. The symptoms of the condition are also usually very difficult to detect until the condition has progressed to an advanced stage.
At present, over 3,000 lawsuits have been filed against Takeda Pharmaceutical Co. for bladder cancer related to the use of Actos. Of these, over 1,200 have been consolidated in a Louisiana federal court to facilitate the exchange of information before the cases go to trial.
Any leading whistleblower law firm tackling the tens of billions of dollars stolen from the
FThe Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b) (the “AKS”), prohibits the payment of kickbacks in any
The False Claim Act, also referred to as the “Lincoln Law,” is a very well-known
The Small Business Administration (“SBA”) recently announced that it has identified over $80 billion in
The Health Insurance Portability and Accountability Act, commonly known as HIPAA, is intended to protect
100 Million Dollar Settlement Fund for Women Injured by a New Birth Control Product
Jason T. Brown was the first attorney in the country to file a battery of cases on behalf of women who sustained blood clots, such as deep vein thrombosis, pulmonary embolisms, strokes and death from a new Birth control Product. Jason T. Brown’s prior firm was on the PSC (Plaintiff Steering Committee) and served as liaison counsel in the state mass tort action. The firm is no longer accepting new cases.
Tens of Millions in Settlements for Mass Tort Injuries and Class Actions
$7 Million Plus Settlement for Consumer Fraud
$7 Million Dollar Commercial Litigation Settlement
Millions in Settlements for Women Injured by New Generation Hormonal Product
Women who sustained blood clots from a new Generation Hormonal Product received and continue to receive compensation for their injuries. Compensable injuries include Pulmonary Embolisms (PE), Deep-Vein Thrombosis (DVT), Strokes and Death. The firm is still investigating and accepting cases.
Nationwide $3.5 Million Settlement for Wage & Hour Class Action Case
Case brought on behalf of at home call center workers who were not paid for all their time worked including boot up time, technical time and other time. Workers were told by the company that boot up time which lasted 15 minutes or more was not paid because it was considered their commute to work. Fair Labor Standards Act (FLSA).
$3.2 Million Settlement for Wage & Hour Class Action Case
Case brought on behalf of workers who were misclassified as salaried exempt from overtime. The employer led employees to believe that they had to work unlimited hours over 40 without overtime compensation even though based on their job duties it was alleged they were entitled to overtime pay.
$2.4 Million Dollar Settlement for Wage & Hour Class Action
Lawsuit was brought as a class action on behalf of workers who worked in excess of 40 hours a week and were not paid overtime. The employer was forcing them to work “off the clock” for those hours and failed to pay proper overtime compensation.
$2 Million Dollar Settlement for False Claims Act (Whistleblower Case)
“$2 Million Dollar False Claims Act (FCA) Settlement – Unnecessary Services”
A case against GenomeDx was brought alleging violations of the False Claims Act (FCA) and the California Insurance Claims Fraud Prevention Act regarding unnecessary services such as the testing of tissues that did not need to be tested. The case resulted in a $350,000 whistleblower award.
$2 Million Dollar Settlement for Truck Accident Victim
Our firm was Of Counsel to a serious truck accident case involving a trucking accident with multiple injuries.
Nationwide $1.3 Million Judgment against Future Income Payments and Scott Kohn for Consumer Fraud
Scott Kohn and Future Income Payments conspired to defraud veterans out of their hard earned pensions by offering them loans at loanshark rates and claiming it was a “purchase” not a loan.
$1.7 Million Dollar Settlement for Wage & Hour Case
Misclassified employees under the FLSA were not paid overtime for hours worked in excess of 40. Due to a confidentiality agreement specific details are intentionally omitted.
Judgment with Maximum Damages for Employment Litigation
Judgment for misclassification under the FLSA including maximum damages under State and Federal Laws, plus an incentive fee for the lead plaintiff with attorney fees paid separately. The case involved a worker who was paid a day rate regardless of the amount of hours worked per day and per week.
Class Action Jury Trial
Workers alleged that they were misclassified according to their job duties. The Defendant claimed an administrative exemption under the FLSA and state law. Misclassification cases under the FLSA are the cases most often tried due to non-monetary considerations. Jury Trial lasted three weeks. Settlement offered in lieu of appeal.
Acquittal at Trial
Despite videotaped evidence that the prosecutor alleged incriminated the defendant, Mr. Brown was able to obtain an acquittal at trial for his client. Please note, that while we, the Brown, LLC will provide consultations in defense matters, the firm spends most of its time litigating complex litigation such as class actions, mass torts and catastrophic injuries.
Judgment with Maximum Damages for Wage & Hour Dispute
Wage & Hour dispute on behalf of hourly employees who were not paid time and a half for hours in excess of 40. Employees were granted double damages for all their time with attorney fees and costs paid separately.
Million Dollar Settlement for Wage & Hour Class Action Case
Workers were compelled to come into work 15 minutes early to set up, but were not paid for their set up time. Gap issues aside, workers received double damages for the time worked for 3 years’ worth of pay with attorney fees paid separately.
This is a non-exhaustive list of prior results and successes of Jason T. Brown and the Brown, LLC. Past results do not guarantee a similar outcome.
For more information about each award see Awards & Accolades – All cases involve Jason T. Brown and/ or Brown, LLC
No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
Results may vary depending on your particular facts and legal circumstances.